3 research outputs found

    Reuse of Sludge as Organic Soil Amendment: Insights into the Current Situation and Potential Challenges

    Get PDF
    Sludge generation as an organic by-product of wastewater treatment has seen a consistent increase worldwide due to population growth and industrial activities. This poses a chronic challenge regarding management options and environmental concerns. The agricultural valorization of unconventional organic materials has become inevitable, especially in semi-arid and arid countries that suffer from depleted soils and shortages in farm manure supply. High-income countries have also been interested in this recycling practice to mitigate landfilling or incineration issues. Sewage and some industrial sludges contain a complex mixture of beneficial and harmful substances, which varies with the origin of effluents. Therefore, sludge land application should be well managed in order to achieve sustainable agro-environmental goals. This review paper focuses on different aspects related to sludge reuse in agriculture, starting by investigating the diversity of sludge types and composition. In addition to the preponderant urban sewage sludge, the less-studied industrial sludges, such as those generated from pulp and paper mills or gas-to-liquid industries, are hereby addressed as well. Then, post-land application effects are discussed in relation to sludge quality, dose, and reuse conditions. The present paper also examines the disparities between guidelines that determine sludge conformity for land application in various countries or regions. Accordingly, special attention is given to increasing risks related to emerging pollutants in sludge such as pharmaceuticals, which have been overused since the outbreak of COVID-19 pandemic. This exhaustive investigation will assist the establishment of sustainable strategies for the safe agricultural reuse of biosolids.This review paper is an outcome of the research project M-QJRC-2020-9 funded in the framework of collaboration between Qatar University and Marubeni Corporation.Scopu

    Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

    Get PDF
    Background: The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods: This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. Findings: This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (74·0%) had emergency surgery and 280 (24·8%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (26·1%) patients. 30-day mortality was 23·8% (268 of 1128). Pulmonary complications occurred in 577 (51·2%) of 1128 patients; 30-day mortality in these patients was 38·0% (219 of 577), accounting for 81·7% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 1·75 [95% CI 1·28–2·40], p\textless0·0001), age 70 years or older versus younger than 70 years (2·30 [1·65–3·22], p\textless0·0001), American Society of Anesthesiologists grades 3–5 versus grades 1–2 (2·35 [1·57–3·53], p\textless0·0001), malignant versus benign or obstetric diagnosis (1·55 [1·01–2·39], p=0·046), emergency versus elective surgery (1·67 [1·06–2·63], p=0·026), and major versus minor surgery (1·52 [1·01–2·31], p=0·047). Interpretation: Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. Funding: National Institute for Health Research (NIHR), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research
    corecore